| Recent trends on wound management: New therapeutic choices based on polymeric carriers ME Okur, ID Karantas, Z Şenyiğit, NÜ Okur, PI Siafaka Asian Journal of Pharmaceutical Sciences 15 (6), 661-684, 2020 | 271 | 2020 |
| Porous dressings of modified chitosan with poly (2-hydroxyethyl acrylate) for topical wound delivery of levofloxacin PI Siafaka, AP Zisi, MK Exindari, ID Karantas, DN Bikiaris Carbohydrate polymers 143, 90-99, 2016 | 142 | 2016 |
| Current update on nanoplatforms as therapeutic and diagnostic tools: a review for the materials used as nanotheranostics and imaging modalities PI Siafaka, N Üstündağ Okur, ID Karantas, ME Okur, E Atlıhan Gündoğdu | 137 | 2020 |
| Diabetes Mellitus: a review on pathophysiology, current status of oral pathophysiology, current status of oral medications and future perspectives ME Okur, ID Karantas, PI Siafaka ACTA Pharmaceutica Sciencia 55 (1), 2017 | 119 | 2017 |
| Dyslipidemia management in 2020: an update on diagnosis and therapeutic perspectives ID Karantas, ME Okur, NÜ Okur, PI Siafaka Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2021 | 15 | 2021 |
| Hypertension in 2017: Update in treatment and pharmaceutical innovations ME Okur, ID Karantas, NU Okur, PI Siafaka Current Pharmaceutical Design 23 (44), 6795-6814, 2017 | 15 | 2017 |
| An updated review for the diabetic wound healing systems ME Okur, EÖ Bülbül, G Mutlu, K Eleftherıadou, ID Karantas, NÜ Okur, ... Current Drug Targets 23 (4), 393-419, 2022 | 14 | 2022 |
| Transdermal drug delivery systems and their potential in Alzheimer’s disease management PI Siafaka, EÖ Bülbül, G Mutlu, ME Okur, ID Karantas, NÜ Okur CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2020 | 13 | 2020 |
| Protein and gene delivery systems for neurodegenerative disorders: where do we stand today? PI Siafaka, ME Okur, PD Erim, EŞ Çağlar, E Özgenç, E Gündoğdu, ... Pharmaceutics 14 (11), 2425, 2022 | 10 | 2022 |
| Detecting and targeting neurodegenerative disorders using electrospun nanofibrous matrices: current status and applications PI Siafaka, E Özcan Bülbül, P Dilsiz, ID Karantas, ME Okur, ... Journal of drug targeting 29 (5), 476-490, 2021 | 9 | 2021 |
| Polymeric microparticles as alternative carriers for antidiabetic glibenclamide drug PI Siafaka, EŞ Cağlar, K Papadopoulou, V Tsanaktsis, ID Karantas, ... Pharmaceutical and Biomedical Research, 2019 | 8* | 2019 |
| The application of nanogels as efficient drug delivery platforms for dermal/transdermal delivery PI Siafaka, E Özcan Bülbül, ME Okur, ID Karantas, N Üstündağ Okur Gels 9 (9), 753, 2023 | 7 | 2023 |
| Delivering active molecules to the eye; the concept of electrospinning as potent tool for drug delivery systems PI Siafaka, EÖ Bülbül, AN Miliotou, ID Karantas, ME Okur, NÜ Okur Journal of Drug Delivery Science and Technology 84, 104565, 2023 | 7 | 2023 |
| An updated review for hyperuricemia and gout management; special focus on the available drug delivery systems and clinical trials ID Karantas, AN Miliotou, PI Siafaka Current Medicinal Chemistry, 2024 | 5 | 2024 |
| Schizophrenia; a review on promising drug delivery systems EÖ Bülbül, ID Karantas, ME Okur, PI Siafaka, NÜ Okur Current Pharmaceutical Design 26 (31), 3871-3883, 2020 | 3 | 2020 |
| Nano-based carriers for pulmonary drug delivery: A review on the available drug delivery applications and toxicity issues PI Siafaka, EÖ Bülbül, AN Miliotou, ID Karantas, ME Okur, NÜ Okur Journal of Drug Delivery Science and Technology, 105381, 2024 | 2 | 2024 |
| Phytochemical compounds loaded to nanocarriers as potential therapeutic substances for Alzheimer's Disease-Could they be effective? DÇ Polat, AE Karadağ, REP Köprülü, ID Karantas, G Mutlu, EŞ Çağlar, ... Current pharmaceutical design, 2022 | 2 | 2022 |
Panoraia I. SiafakaEuropean University Cyprus在 euc.ac.cy 的电子邮件经过验证
Panoraia I. SiafakaEuropean University Cyprus在 euc.ac.cy 的电子邮件经过验证
Mehmet Evren OkurUniversity of Health Sciences在 sbu.edu.tr 的电子邮件经过验证